The March 2014 revived the history of discovery of Ebola virus dated back in 1976, when a 27 year old researcher from Belgian became its victim traveling to remote area in central Africa. Recently, West Africa is combating against Ebola outbreaks. Since March, the virus has made more than 3,000 people suffered and has called for an immediate cry to help.
The viral epidemics have affected individuals dwelling in Guinea, Nigeria and Sierra Leone in large numbers. According to WHO statistical report on Ebola upsurge, more than 1,550 people contracting this disease have died. However two people with the medicinal aid by American Hospital were the first to get managed for Ebola infection.
The treatment was carried out for three weeks and the victims were released safe and healthy out of the hospital door on 21 August.
As in medicine, it is frequently cited that “Prevention is better than cure”, the scientists all over the world are struggling to define the protection against this virus. The virus causes fever and flu like symptoms which were followed by hemorrhage resulting in life threatening condition due to lack of blood to flow though the vital organs. Being a potential warning to your life, the management is indeed an important topic for discussion.
The hype that is revolving the air these days is the success in introducing an Ebola vaccine made from Chimpanzee cold virus acting as vector for carrying pieces for Ebola genes. The vaccine was used in a trail based research study on monkeys. Nevertheless the vaccine alone did not resulted in complete eradication of infection as the effect wanes off with time, however manufacturing a booster shot has provided much satisfactory results. The analysis suggesting that single shot of vaccine has to be followed by a second booster dose, has made the process of prevention against Ebola quite effective. Since there is no licensed way to treat this disease, the vaccine is of significant importance in bringing the edge of eradicating Ebola one step closer.
Dr.Anthony Fauci, director of National Institute of Allergy and Infectious disease working on the vaccine project said the two way prevention is good , although he is not in favor of single vaccination but considered that partial immunization is better, however the aim must be for a longer period of time, therefore trying booster shots must be equally necessary and mandatory.
In his experiment he injected boosters in previously vaccinated monkeys after 5 weeks of Ebola infection, and saw good results suggesting use of boosters simultaneously with the vaccine.
The World Health Organization expects the vaccine to be tried on healthy individuals as the previous experiment covers animals like monkeys; both have different modes of combating the disease. Recently Manufactures New Link Genetics Corporation, AMES are approved by FDA for testing similar vaccine made for humans. The Phase 1 clinical trial will soon be started; it will be the first ever in the history when humans will be made research volunteers for Ebola vaccination.